Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting

BMC Cancer
Hillary MabeyaDavy Vanden Broeck

Abstract

All women are potentially at risk of developing cervical cancer at some point in their life, yet it is avoidable cause of death among women in Sub- Saharan Africa with a world incidence of 530,000 every year. It is the 4th commonest cancer affecting women worldwide with over 260,000 deaths reported in 2012. Low resource settings account for over 75% of the global cervical cancer burden. Uptake of HPV vaccination is limited in the developing world. WHO recommended that 2 doses of HPV vaccine could be given to young girls, based on studies in developed countries. However in Africa high rates of infections like malaria and worms can affect immune responses to vaccines, therefore three doses may still be necessary. The aim of this study was to identify barriers and facilitators associated with uptake of HPV vaccine. A cross-sectional survey was conducted at Eldoret, Kenya involving 3000 girls aged 9 to 14 years from 40 schools. Parents/guardians gave consent through a questionnaire. Of all 3083 the school girls 93.8% had received childhood vaccines and 63.8% had a second HPV dose, and 39.1% had a third dose. Administration of second dose and HPV knowledge were both strong predictors of completion of the third dose. Distance to the ...Continue Reading

References

Sep 1, 1991·Reviews of Infectious Diseases·P A PatriarcaT J John
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Mar 29, 2002·Journal of Clinical Pathology·F X BoschK V Shah
Sep 5, 2006·Vaccine·Gregory D ZimetBetania Allen
Mar 21, 2007·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Charlotte H LenselinkRuud L M Bekkers
Sep 28, 2007·World Journal of Surgery·B Ramana
May 3, 2008·Trends in Parasitology·Gadi Borkow, Zvi Bentwich
Jun 16, 2009·Biologicals : Journal of the International Association of Biological Standardization· Who
Jun 23, 2010·Vaccine·Sylvia Becker-DrepsJennifer S Smith
Mar 20, 2012·Journal of Community Health·Claudine Akono AyissiJavier Gordon Ogembo
Oct 30, 2012·Journal of the National Cancer Institute·Nicolas Van de VeldeMarc Brisson
Aug 24, 2013·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·K RichterG Dreyer
Jun 27, 2015·PloS One·Deborah Watson-JonesDavid A Ross

❮ Previous
Next ❯

Software Mentioned

STATA
GAVI

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.